1,1,1-trifluoro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide

Catalog No. :
ACTRNO672
CAS No. :
1605331-75-6
Molecular Formula :
C13H17BF3NO4S
Molecular Weight :
351.15

IUPAC Name:1,1,1-trifluoro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide

1,1,1-trifluoro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$188.00Login to see priceInquiryInquiry
250mg98%$387.00Login to see priceInquiryInquiry
1g98%$799.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,1,1-trifluoro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide
IUPAC Name1,1,1-trifluoro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide
Molecular FormulaC13H17BF3NO4S
Molecular Weight351.15
SMILESCC1(C)OB(C2=CC(NS(=O)(=O)C(F)(F)F)=CC=C2)OC1(C)C
InChI KeyRBFSYFCTXISCML-UHFFFAOYSA-N
Synonym1,1,1-trifluoro-N-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanesulfonamide;Methanesulfonamide, 1,1,1-trifluoro-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-
CAS No.1605331-75-6

Synthetic Route by SureRoute

1. ACTRNO672 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTRNO672 route product structure diagram
    ACTRNO6721605331-75-6
Inquiry

2. ACTRNO672 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHZLA740 route compound structure diagram
    ACHZLA740210907-84-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTRNO672 route product structure diagram
    ACTRNO6721605331-75-6
Inquiry

Comments (0)